| Released | Contributor | Author | Title | Pages | Price |
| 8-Dec-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Industry Report for BIOTECHNOLOGY | 18 |
$49 |
| 8-Dec-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Comprehensive Rating Report | 48 |
$99 |
| 8-Dec-2009 | EconomicInvestor |
N/A
| "The Economy Matters" Report for CSII: the economy's impact on CSII's price and risk, featuring the powerful EconomicInvestor Star Rating | 6 |
$15 |
| 7-Dec-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Detailed Valuation Report for CSII | 13 |
$25 |
| 3-Dec-2009 | Ford Investor Services, Inc. |
N/A
| Industry Value Graph: ACAD , CSII , CERS , CRXX , GTXI , SGMO , UGNE -- DRUGS | 3 |
$4 |
| 3-Dec-2009 | Ford Investor Services, Inc. |
N/A
| Value Graph: CARDIOVASCULAR -- CSII | 1 |
$4 |
| 2-Dec-2009 | Life Science Analytics | Life Science Analytics | Cardiovascular Systems Inc.-Company Report | 9 |
$85 |
| 25-Nov-2009 | Zacks Investment Research Inc. |
N/A
| CARDIOVASCLR SY (CSII) Zacks Company Snapshot | 1 |
$10 |
| 23-Nov-2009 | Argus Research Corporation | David Coleman | Vickers Weekly Insider, 11/23/09 | 52 |
$50 |
| 23-Nov-2009 | Directors Deals Ltd. | Company Snapshot | Company Snapshot - Cardiovascular Systems Inc | 1 |
$10 |
0.50% Nasdaq 
Research Reports
